| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
491,390,000 |
| Market
Cap: |
8.45(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$8.08 - $17.2 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 11.5 |
| Insider 6 Months : 11.5 |
| Insider 3/6 Months : 23 |
|
| Guru Rank Number : 235 |
| Guru Rank Value : 5.2 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Elanco Animal Health is an animal health company. Co. groups its products into four principal categories: Companion Animal (CA) Disease Prevention, which includes parasiticides and vaccine products for canines and felines; CA Therapeutics, which includes products for the treatment of pain, osteoarthritis, otitis, cardiovascular and dermatology indications in canines and felines; Food Animal (FA) Future Protein and Health, which includes vaccines, antibiotics, parasiticides and other products used in poultry and aquaculture production; and FA Ruminants and Swine, which includes vaccines, antibiotics, implants, parasiticides and other products used in ruminants and swine production.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
38,100 |
38,100 |
38,100 |
147,300 |
| Total Buy Value |
$617,802 |
$617,802 |
$617,802 |
$2,195,450 |
| Total People Bought |
3 |
3 |
3 |
7 |
| Total Buy Transactions |
3 |
3 |
3 |
11 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Hoover R David |
Director |
– • – |
2020-03-13 |
4 |
B |
$21.97 |
$263,640 |
I/I |
12,000 |
40,000 |
2.1 |
4% |
|
| Harrington Michael J |
Director |
– • – |
2020-03-09 |
4 |
B |
$23.84 |
$95,360 |
D/D |
4,000 |
16,799 |
2.39 |
-9% |
|
| Bilbrey John P |
Director |
– • – |
2020-03-06 |
4 |
B |
$25.15 |
$75,450 |
I/I |
3,000 |
14,642 |
2.1 |
-8% |
|
| Anand Kapila K |
Director |
– • – |
2020-03-04 |
4 |
B |
$26.86 |
$26,860 |
D/D |
1,000 |
13,275 |
2.39 |
-15% |
|
| Young Todd S. |
See Remarks |
• – – |
2020-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
14,840 |
41,513 |
|
- |
|
| Hoover R David |
Director |
– • – |
2020-03-02 |
4 |
B |
$27.40 |
$106,860 |
I/I |
3,900 |
28,000 |
2.1 |
-21% |
|
| Schacht Aaron L |
See Remarks |
• – – |
2020-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
12,357 |
66,727 |
|
- |
|
| Kinard David S |
See Remarks |
• – – |
2020-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
6,075 |
67,466 |
|
- |
|
| Urbanek David Alan |
See Remarks |
• – – |
2020-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
6,678 |
67,412 |
|
- |
|
| Hicks Michael-Bryant |
See Remarks |
• – – |
2020-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
42,137 |
|
- |
|
| Cabral Ramiro Martin |
See Remarks |
• – – |
2020-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
8,694 |
44,771 |
|
- |
|
| Simmons Jeffrey N |
President, CEO & Director |
• • – |
2020-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
61,736 |
489,117 |
|
- |
|
| Lin Sarena S |
See Remarks |
• – – |
2020-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
66,051 |
|
- |
|
| Meer James M |
Chief Accounting Officer |
• – – |
2020-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,970 |
7,988 |
|
- |
|
| Young Todd S. |
See Remarks |
• – – |
2020-03-01 |
4 |
D |
$27.40 |
$25,372 |
D/D |
(926) |
26,673 |
|
- |
|
| Schacht Aaron L |
See Remarks |
• – – |
2020-03-01 |
4 |
D |
$27.40 |
$13,755 |
D/D |
(502) |
54,370 |
|
- |
|
| Kinard David S |
See Remarks |
• – – |
2020-03-01 |
4 |
D |
$27.40 |
$20,166 |
D/D |
(736) |
61,391 |
|
- |
|
| Urbanek David Alan |
See Remarks |
• – – |
2020-03-01 |
4 |
D |
$27.40 |
$11,645 |
D/D |
(425) |
60,734 |
|
- |
|
| Hicks Michael-Bryant |
See Remarks |
• – – |
2020-03-01 |
4 |
D |
$27.40 |
$21,893 |
D/D |
(799) |
33,137 |
|
- |
|
| Cabral Ramiro Martin |
See Remarks |
• – – |
2020-03-01 |
4 |
D |
$27.40 |
$9,152 |
D/D |
(334) |
36,077 |
|
- |
|
| Simmons Jeffrey N |
President, CEO & Director |
• • – |
2020-03-01 |
4 |
D |
$27.40 |
$133,794 |
D/D |
(4,883) |
427,381 |
|
- |
|
| Lin Sarena S |
See Remarks |
• – – |
2020-03-01 |
4 |
D |
$27.40 |
$15,865 |
D/D |
(579) |
57,051 |
|
- |
|
| Meer James M |
Chief Accounting Officer |
• – – |
2020-03-01 |
4 |
D |
$27.40 |
$2,302 |
D/D |
(84) |
5,018 |
|
- |
|
| Hoover R David |
Director |
– • – |
2020-02-28 |
4 |
B |
$26.99 |
$110,659 |
I/I |
4,100 |
24,100 |
2.1 |
-22% |
|
| Simmons Jeffrey N |
President, CEO & Director |
• • – |
2020-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
34,339 |
432,264 |
|
- |
|
390 Records found
|
|
Page 12 of 16 |
|
|
0.21 (1.24%) 
